Mertiva AB Profile

Performance

   

 Odds of Distress 

Check how we calculate scores
Equity ratings for Mertiva AB are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting April 18, 2019 and ending today June 17, 2019. Click here to learn more.
Mertiva AB cannot be verified against its exchange. It appears that Mertiva AB is not available for investing at the moment. Please verify the symbol is currently traded on OTC Market. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Mertiva AB Key Fundamentals

Mertiva AB Against Markets

Mertiva AB cannot be verified against its exchange. It appears that Mertiva AB is not available for investing at the moment. Please verify the symbol is currently traded on OTC Market. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Try Other Stock Suggestions

Mertiva AB , through its interest in Mercodia AB, develops, manufactures, and distributes ELISA assays in the areas of diabetes, obesity, and cardiovascular diseases. Mertiva AB was founded in 1994 and is based in Stockholm, Sweden. Mertiva AB is traded on OTC Market in USA.. The public information regarding Mertiva AB's current market price is not available at this time.
NameMertiva AB
CEO and President and DirectorAndreas BergstenView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressEdsvik road 89
ExchangeOTC Market
BenchmarkDOW
Websitewww.mertiva.se
Phone46 86 61 00 26
CurrencyUSD - US Dollar
Additionally see Investing Opportunities. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Search macroaxis.com